Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-22

FDA Approved: TRIENTINE HYDROCHLORIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved an original application for trientine hydrochloride from Novadoz Pharmaceuticals LLC, providing a generic option for Wilson disease treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIENTINE HYDROCHLORIDE (Trientine hydrochloride)

Snippet

ORIG AP for TRIENTINE HYDROCHLORIDE (TRIENTINE HYDROCHLORIDE)